BackODI Pharma AB Overview

ODI Pharma AB Receivables

Latest receivables for ODI.ST: $1.9M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$1.90M
↓ 10.33% YoYΔ $-219113.00 vs prior year quarter

Peer trimmed avg / median

Loading

ODI Pharma AB Receivables History

Loading

ODI Pharma AB vs. peers: Receivables Comparison

Loading

ODI Pharma AB Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

ODI Pharma AB (ODI.ST) FAQ

As of the most recent data (June 2026), ODI.ST shows a receivables of $1.9M. That compares with $2.1M in the prior-year period — down 10.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ODI.ST's receivables is now $1.9M (was $2.1M) — a 10.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether ODI Pharma AB is outperforming or lagging.

Tracking ODI.ST's receivables over time shows whether ODI Pharma AB is scaling, shrinking, or reshaping that part of the business. The current reading is $1.9M That compares with $2.1M in the prior-year period — down 10.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has ODI Pharma AB's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $1.9M) with ownership activity and broader fundamentals.